Medical device company Globus Medical (NYSE ... on improving patient outcomes. Our spine sales force is the most dedicated and talented team in the market. Our innovation engine delivered a ...

Globus Medical, Inc. shines with strong Q4 results & Nevro acquisition, boosting its market position. Click here to find out ...

Annual GAAP net income was $103 million, while non-GAAP adjusted EBITDA stood at $735 million, accounting for 29.2% of total ...

compete successfully (including without limitation success in convincing surgeons to use Globus Medical or Nevro products and the ability to attract and retain sales and other personnel), (vi) rapidly ...

It is hard to get excited after looking at Globus Medical's (NYSE:GMED) recent performance, when its stock has declined 17% over the past three months. It seems that the market might have ...

Globus Medical had set its initial 2025 sales forecast on a standalone basis at $2.66 to $2.69 billion, indicating a year-over-year increase of 6% to 7%, and an adjusted earnings per share (EPS ...